At Fully Functional we stand tall, even though we have faced strong resistance from groups of pro-device users backed by large corporates. We are here for the truth and to serve the spectrum community. We believe this will expand your knowledge so you can make the right decisions and save precious developmental time for your child on the spectrum. Please share this article far and wide.
Photobiomodulation (PBM), commonly marketed as red-light therapy, has become one of the fastest-growing wellness trends in the world. What was once confined to research labs and specialised clinics is now sold as handheld devices, face masks, helmets and full-body panels marketed directly to consumers.
Claims now range from skin rejuvenation and scar reduction to improved cognition, better sleep, faster recovery, autism support, Parkinson's disease, depression and even anti-aging. Naturally, parents of children on the autism spectrum ask:
"If light can influence biology, could it help my child?"
That is an important question. An equally important question — discussed far less — is this: what happens when biological systems are repeatedly exposed to photobiomodulation over months or years?
The Beginning: A Different Scientific Conversation
Photobiomodulation did not begin as a consumer wellness product. Its early development was largely confined to physicists, optical engineers, laser scientists and medical researchers who understood that light is not merely illumination — it is a biological signal.
- Every wavelength carries energy.
- Every wavelength interacts differently with tissue.
- Every wavelength has limits.
As PBM entered clinical medicine, researchers investigated its role in wound healing, oral mucositis in chemotherapy patients, radiation dermatitis, pain management and selected dermatological conditions. Today, evidence supports certain medical uses when appropriate wavelengths, doses and treatment parameters are followed.
But commercialization rapidly outpaced standardization. Thousands of devices entered the market with enormous differences in wavelength, power output, irradiance, treatment duration, pulse frequency and treatment distance. Even today, these parameters are not standardized across devices or manufacturers.
From Medical Equipment to Consumer Product
As aesthetic applications expanded, so did marketing — scar reduction, hair growth, skin tightening, wrinkle reduction, muscle recovery, sleep optimization, brain enhancement, athletic performance, autism. The list kept growing.
Many devices became inexpensive, portable and available over the counter, often with minimal guidance on cumulative exposure, patient selection or long-term monitoring. This does not mean PBM is unsafe — current clinical reviews generally conclude it is well tolerated within studied treatment parameters. The challenge is that marketing claims frequently extend beyond the evidence base.
Why This Matters in Autism
Children on the autism spectrum frequently show biological characteristics that differ from neurotypical populations, including differences reported in:
- sensory processing
- autonomic nervous system regulation
- circadian rhythm
- visual sensitivity
- arousal regulation
These differences may influence how an individual experiences environmental stimuli — including light. That does not automatically mean PBM is harmful or beneficial for autistic individuals. It suggests responses may be more variable and deserve careful clinical observation instead of a one-size-fits-all approach.
Light is biology.
We Have Also Experienced Resistance
As our team began discussing potential concerns regarding prolonged photobiomodulation exposure in sensitive individuals, we encountered considerable resistance online. Discussions around red-light therapy can become highly polarized. While many report positive experiences, others who raise questions about dosing, individual variability or adverse experiences often feel dismissed.
Science progresses through questioning — not through silencing questions. Our objective is not to attack photobiomodulation. Our objective is to understand it.
One Important Word: Prolonged
"Prolonged exposure" is highly individual. There is no universal definition. For one child, three sessions per week may be excessive. For another, one session a month may still represent a biological stressor.
Factors likely to influence response include:
- nervous system sensitivity
- baseline autonomic regulation
- sensory profile
- sleep quality
- mitochondrial biology
- medication use
- concurrent therapies
This is precisely why individualized clinical observation is essential.
The Three Hidden Biological Pathways
These mechanisms are not presented as proof that PBM causes behavioural changes in autism. Rather, they are biologically plausible pathways that help explain why some individuals may perceive visual discomfort, increased alertness or agitation following prolonged red-light exposure and a subsequent return to ordinary lighting.
1. Photoreceptor Adaptation (Cone Adaptation)
The retina contains cone cells responsible for colour vision. Red light predominantly stimulates L-cones, which are most sensitive to longer wavelengths. During prolonged red-light exposure, L-cones gradually reduce their sensitivity — a normal protective adaptation. Meanwhile, the S-cones (blue light) remain comparatively unadapted because they were minimally stimulated.
When the individual suddenly returns to normal daylight or indoor LED lighting, the blue-sensitive system may temporarily appear disproportionately strong. The result may include:
- blue light appearing unusually harsh
- increased glare
- visual discomfort
- greater sensory salience of blue-rich environments
This is a normal phenomenon of sensory adaptation rather than tissue injury.
2. Opponent-Process Rebound
Human colour perception operates through opponent colour channels — one of the major channels compares blue versus yellow. During prolonged red-light exposure, activity within this colour-processing system becomes temporarily biased. When exposure ends, the previously suppressed pathway may briefly "rebound." This relates to the same physiological principles responsible for colour afterimages.
Possible experiences include:
- blue colours appearing unusually vivid
- visual harshness
- temporary glare
- exaggerated colour contrast
For children already experiencing sensory hypersensitivity, even a temporary amplification of visual input may contribute to behavioural discomfort.
3. Melanopsin (ipRGC) Activation — The Hidden Arousal Pathway
Perhaps the least appreciated mechanism involves intrinsically photosensitive retinal ganglion cells (ipRGCs). Unlike cones, these cells are not primarily responsible for seeing images. Instead, they regulate circadian rhythm, pupil size, alertness and autonomic arousal. They are particularly sensitive to blue wavelengths (around 480 nm).
During prolonged red-light exposure, their activity remains relatively low. When the eyes are suddenly exposed to blue-rich light, ipRGC activity rapidly increases. This can produce:
- rapid pupil constriction
- increased alertness
- activation of brain regions involved in circadian regulation
- a transient shift toward sympathetic ("fight-or-flight") nervous system activity
Some individuals may perceive this not simply as brighter light, but as internal agitation or restlessness.
What Does This Mean for Autism?
These three pathways provide biological hypotheses for why some individuals may report discomfort after prolonged red-light exposure followed by ordinary blue-enriched lighting. They should not be interpreted as evidence that photobiomodulation is harmful for autistic children or that it should never be used.
A Balanced Perspective
At Fully Functional Autism, we encourage families to approach every emerging therapy with both curiosity and caution. Ask:
- What biological pathway is being targeted?
- What evidence supports its use for my child's condition?
- What dose has been studied?
- Are there long-term safety data for children?
- How will response be objectively monitored?
Science advances by asking better questions — not by assuming every new technology is either a miracle or a menace. Photobiomodulation is a fascinating field with genuine medical applications. At the same time, its rapid commercialization reminds us that thoughtful, individualized care should always come before marketing claims.
For children on the autism spectrum, understanding how light interacts with biology may be just as important as understanding whether it works.